Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Luke

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
American Journal of Surgery|February 6, 1999
Treatment of acute gynecologic infections with trovafloxacin. Trovafloxacin Surgical GroupS Roy, W Koltun, A Chatwani, et al.
Biopharmaceutics & Drug Disposition|April 1, 1990
Influence of lovastatin on the pharmacokinetics, toxicity and immunologic response of cyclosporine in the obese Zucker ratK L Berens, K Vadiei, L J Brunner, et al.
Progress in Clinical and Biological Research|January 1, 1990
Impact of time and feeding habits on lipid levels in Zucker obese ratsL J Brunner, K M Wasan, K Vadiei, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1996
The absence of an effect of food on the bioavailability of azithromycin administered as tablets, sachet or suspensionG Foulds, D R Luke, R Teng, et al.
Transplantation|September 1, 1990
Evaluation of amphotericin B-cyclosporine interaction in the ratJ D Langston, K M Wasan, G Lopez-Berestein, et al.
Pharmacotherapy|January 1, 1991
Therapeutic drug monitoring of cyclosporine-lipoprotein levelsJ C Yau, L J Brunner, G Lopez-Berestein, et al.
Transplantation|June 1, 1987
Effects of cyclosporine on the isolated perfused rat kidneyD R Luke, B L Kasiske, G R Matzke, et al.
Therapeutic Drug Monitoring|June 1, 1992
Bioavailability of labetalol in patients with end-stage renal diseaseD R Luke, W M Awni, C E Halstenson, et al.
Chronobiology International|January 1, 1989
Circadian assessment of lipids in the hyperphagic obese rat compared with lean litter-matesK M Wasan, L J Brunner, K L Berens, et al.
Journal of Clinical Pharmacology|February 1, 1990
Longitudinal study of cyclosporine and lipids in patients undergoing bone marrow transplantationD R Luke, J E Beck, K Vadiei, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
American Journal of Surgery|February 6, 1999
Treatment of acute gynecologic infections with trovafloxacin. Trovafloxacin Surgical GroupS Roy, W Koltun, A Chatwani, et al.
Biopharmaceutics & Drug Disposition|April 1, 1990
Influence of lovastatin on the pharmacokinetics, toxicity and immunologic response of cyclosporine in the obese Zucker ratK L Berens, K Vadiei, L J Brunner, et al.
Progress in Clinical and Biological Research|January 1, 1990
Impact of time and feeding habits on lipid levels in Zucker obese ratsL J Brunner, K M Wasan, K Vadiei, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1996
The absence of an effect of food on the bioavailability of azithromycin administered as tablets, sachet or suspensionG Foulds, D R Luke, R Teng, et al.
Transplantation|September 1, 1990
Evaluation of amphotericin B-cyclosporine interaction in the ratJ D Langston, K M Wasan, G Lopez-Berestein, et al.
Pharmacotherapy|January 1, 1991
Therapeutic drug monitoring of cyclosporine-lipoprotein levelsJ C Yau, L J Brunner, G Lopez-Berestein, et al.
Transplantation|June 1, 1987
Effects of cyclosporine on the isolated perfused rat kidneyD R Luke, B L Kasiske, G R Matzke, et al.
Therapeutic Drug Monitoring|June 1, 1992
Bioavailability of labetalol in patients with end-stage renal diseaseD R Luke, W M Awni, C E Halstenson, et al.
Chronobiology International|January 1, 1989
Circadian assessment of lipids in the hyperphagic obese rat compared with lean litter-matesK M Wasan, L J Brunner, K L Berens, et al.
Journal of Clinical Pharmacology|February 1, 1990
Longitudinal study of cyclosporine and lipids in patients undergoing bone marrow transplantationD R Luke, J E Beck, K Vadiei, et al.
Pageof 7